Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Apr;88(1):138–142. doi: 10.1111/j.1365-2249.1992.tb03053.x

Expression of the 40 kD protein in DLD-1 colon cancer cells and the effect of cytokines.

K M Das 1, L Squillante 1, F Robertson 1
PMCID: PMC1554375  PMID: 1373349

Abstract

We recently reported the presence of an organ-specific 40 kD colonic protein which acts as an autoantigen(s) in patients with ulcerative colitis. Using a specific monoclonal antibody directed against 40 kD protein (7E12H12, IgM isotype), in conjunction with immunocytochemistry and flow cytometry, we examined the presence of the 40 kD protein on human colon cancer cells, DLD-1, and also characterized the ability of cytokines, IFN-gamma and tumour necrosis factor, to modulate the expression of this protein on these tumour cells. The presence of the 40 kD protein was localized to the plasma membrane; less was present within the cytoplasm. Following exposure to IFN-gamma (10-1000 U/ml), DLD-1 colon tumour cells showed a dose- and time-dependent increase in 7E12H12 antibody associated immunofluorescence, with the maximum 7E12H12 antibody binding observed with 100 U/ml IFN-gamma at 48 h. In contrast, tumour necrosis factor did not alter the levels of anti-40 kD antibody binding over that of control cells. Since IFN-gamma is also known to induce class II major histocompatibility antigens, we examined the possibility of cross-reactivity of HLA class II antigens and Mr 40 kD epitope. Neither pre-incubation of DLD-1 colon tumour cells with anti-HLA class II antibodies followed by 7E12H12 nor co-incubation of both antibodies altered the amount of 7E12H12 antibody binding. Using a direct ELISA, a highly enriched preparation of Mr 40 kD protein reactive to anti-40 kD antibody did not react with HLA class II antibodies. The present results suggest that 40 kD protein is present on DLD-1 human colon tumour cells and that although the 40 kD protein epitope expression is increased by the lymphocyte-derived cytokine, IFN-gamma, the epitope is separate and distinct from the class II HLA antigens. Further studies on the 40 KD protein may elucidate its autoantigenic role in the pathogenesis of inflammatory bowel disease.

Full text

PDF
138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auer I. O., Grosch L., Hardörfer C., Röder A. Ulcerative colitis specific cytotoxic IgG-autoantibodies against colonic epithelial cancer cells. Gut. 1988 Dec;29(12):1639–1647. doi: 10.1136/gut.29.12.1639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bland P. MHC class II expression by the gut epithelium. Immunol Today. 1988 Jun;9(6):174–178. doi: 10.1016/0167-5699(88)91293-5. [DOI] [PubMed] [Google Scholar]
  3. Bottazzo G. F., Dean B. M., McNally J. M., MacKay E. H., Swift P. G., Gamble D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985 Aug 8;313(6):353–360. doi: 10.1056/NEJM198508083130604. [DOI] [PubMed] [Google Scholar]
  4. Campbell I. L., Oxbrow L., Koulmanda M., Harrison L. C. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol. 1988 Feb 15;140(4):1111–1116. [PubMed] [Google Scholar]
  5. Das K. M., Kadono Y., Fleischner G. M. Antibody-dependent cell-mediated cytotoxicity in serum samples from patients with ulcerative colitis. Relationship to disease activity and response to total colectomy. Am J Med. 1984 Nov;77(5):791–796. doi: 10.1016/0002-9343(84)90514-x. [DOI] [PubMed] [Google Scholar]
  6. Das K. M., Sakamaki S., Vecchi M., Diamond B. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol. 1987 Jul 1;139(1):77–84. [PubMed] [Google Scholar]
  7. Das K. M., Sakamaki S., Vecchi M. Ulcerative colitis: specific antibodies against a colonic epithelial Mr 40,000 protein. Immunol Invest. 1989 Jan-May;18(1-4):459–472. doi: 10.3109/08820138909112256. [DOI] [PubMed] [Google Scholar]
  8. Das K. M., Vecchi M., Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology. 1990 Feb;98(2):464–469. doi: 10.1016/0016-5085(90)90839-s. [DOI] [PubMed] [Google Scholar]
  9. Kawanishi H. Recent progress in immune responses in gut. Dig Dis. 1989;7(3):113–124. doi: 10.1159/000171211. [DOI] [PubMed] [Google Scholar]
  10. Mayer L., Shlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med. 1987 Nov 1;166(5):1471–1483. doi: 10.1084/jem.166.5.1471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nagai T., Das K. M. Demonstration of an assay for specific cytolytic antibody in sera from patients with ulcerative colitis. Gastroenterology. 1981 Jun;80(6):1507–1512. [PubMed] [Google Scholar]
  12. Qin O. Y., el-Youssef M., Yen-Lieberman B., Sapatnekar W., Youngman K. R., Kusugami K., Fiocchi C. Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma. Dig Dis Sci. 1988 Dec;33(12):1528–1536. doi: 10.1007/BF01535942. [DOI] [PubMed] [Google Scholar]
  13. Quaroni A., Weiser M. M., Herrera L., Fay D. Crypt cell antigens (CCA): new carbohydrate markers for human colon cancer cells. Immunol Invest. 1989 Jan-May;18(1-4):391–404. doi: 10.3109/08820138909112251. [DOI] [PubMed] [Google Scholar]
  14. Spriggs D. R., Imamura K., Rodriguez C., Sariban E., Kufe D. W. Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest. 1988 Feb;81(2):455–460. doi: 10.1172/JCI113341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sugiyama T., Brown W. R., Ahnen D. J. Expression of cell-surface antigens on rat colonic cancer cells. Gastroenterology. 1988 Feb;94(2):331–342. doi: 10.1016/0016-5085(88)90420-9. [DOI] [PubMed] [Google Scholar]
  16. Takahashi F., Das K. M. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. J Clin Invest. 1985 Jul;76(1):311–318. doi: 10.1172/JCI111963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Takahasi F., Shah H. S., Wise L. S., Das K. M. Circulating antibodies against human colonic extract enriched with a 40 kDa protein in patients with ulcerative colitis. Gut. 1990 Sep;31(9):1016–1020. doi: 10.1136/gut.31.9.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Volc-Platzer B., Leibl H., Luger T., Zahn G., Stingl G. Human epidermal cells synthesize HLA-DR alloantigens in vitro upon stimulation with gamma-interferon. J Invest Dermatol. 1985 Jul;85(1):16–19. doi: 10.1111/1523-1747.ep12274511. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES